跳至主要内容
临床试验/NCT01687049
NCT01687049Unknown2 期

A Prospective Study of Red Yeast Rice in Subjects With Clinically Localized Prostate Cancer Undergoing Active Surveillance

Dr. Laurence Klotz1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2013年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
发起方
入组人数
60
试验地点
1
主要终点
Expression of Ki-67 and p27 biomarkers

研究概览

简要总结

Agents that inhibit cholesterol synthesis are being investigated in cancers dependent upon cholesterogenesis. Red yeast rice (RYR), is a reddish-purple fermented rice, containing statins which are known to inhibit cholesterol synthesis. Laboratory studies have also shown that RYR has direct effects on androgen dependent and androgen independent prostate cancer cells, inhibiting their growth. It is thought that RYR may have clinical benefit in those subjects with localized prostate cancer who have chosen to be managed by active surveillance.

详细描述

Red yeast rice has been promoted as a safe and effective alternative to statin therapy in the treatment of hypercholesterolemia. Red yeast rice has the potential to slow prostate cancer growth by inhibiting cholesterol and androgen biosynthesis. There is a strong rationale for the use of RYR in patients being managed with active surveillance for localized, low risk, prostate cancer. To date, no human studies utilizing RYR in this setting have been reported.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
19 Years 至 90 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • histologically diagnosis of prostate adenocarcinoma
  • being monitored by active surveillance for favourable risk prostate cancer
  • tumour material from most recent prostate biopsy available with sample
  • scheduled to have an active surveillance mandated transrectal ultrasound (TRUS) guided biopsy within 6 - 12 months of Day 1 of the study

排除标准

  • previous malignancy in the past 5 years
  • no previous or concurrent treatment for prostate cancer
  • inability to undergo TRUS biopsy
  • ECOG > 2
  • known or previous history of liver disease

研究组 & 干预措施

red yeast rice (RYR)

Experimental

Two RYR capsules three times daily for a minimum of 6 months

干预措施: Red yeast rice (Drug)

结局指标

主要结局

Expression of Ki-67 and p27 biomarkers

时间窗: 6 months

Determine effect of red yeast rice therapy on expression of ki67 and p27 biomarkers in a post-treatment biopsy

次要结局

  • PSA kinetics(6 months)
  • Presence of prostatic interepithelial neoplasia(6 months)
  • Expression of hs-CRP and cardiac CRP(6 months)

研究者

发起方
Dr. Laurence Klotz
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Dr. Laurence Klotz

Principal Investigator

Sunnybrook Health Sciences Centre

研究点 (1)

Loading locations...

相似试验